Xin Yi Wong

4PUBLICATIONS
11CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 02, 2025
Cost-effectiveness of ruxolitinib in Singapore for patients with chronic graft-versus-host disease.

Naren Kumar Surendra, Jiamin Ong, Xin Yi Wong

|Oct 16, 2023
Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent Lymphoma.

Chia Jie Tan, Melinda Si Yun Tan, Chandramouli Nagarajan

|Dec 14, 2021
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myeloma.

Xin Yi Wong, Wee Joo Chng, Mohamed Ismail Abdul Aziz

|Jul 02, 2020
Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.

Xin Yi Wong, Andrew Qi Jun Lim, Qianyu Shen

Pageof 1